News

DaraEx and Mezagitamab

We are pleased to announce the publication of a new study ⧉ highlighting the effectiveness of DaraEx in overcoming interference caused by mezagitamab during serological pre-transfusion testing.

T Cell Staining Reagent available now

Visit our Shop to discover Dyemer, imusyn's novel T cell staining reagent.

Or have a look at our unmatched panel of recombinant HLA class I and class II proteins.

DaraEx plus

A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.

DaraEx plus is available from inno-train ⧉.

imuPep Class I Peptide Binding Analysis

Our innovative, high-throughput service for you to confirm your target peptides, e.g. in vaccine and cancer research.

New IFU Versions

New versions of the IFU for rBGA are now available (release 2025/05).

Certificate Available for Download

EN ISO 13485:2016, issued May 09^th, 2023

Certificate Directive 98/79/EC, issued May 20^th, 2022

Welcome to imusyn.

Our mission is to develop and produce outstanding diagnostic tests in the field of transfusion medicine and organ transplantation. We also support the development of in-vitro diagnostics and provide customized recombinant protein production.